Information Technology · Printed Circuit Boards

KE Kimball Electronics, Inc. SEC Filings & Insider Trading Activity 2026

company
CIK 160675774 filings
Russell 2000

KE at a glance

Kimball Electronics, Inc. (KE, SEC CIK 1606757) filed its latest 10-K annual report on August 19, 2026, a 10-Q quarterly report on May 6, 2026, an 8-K current report on August 12, 2026 and Form 4 insider filings as recently as September 4, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended June 30, 2026 (FY2026), Kimball Electronics, Inc. (KE) reported revenue of $1.4 billion (down 3.7% from FY2025) and net income of $28.0 million. Diluted EPS was $1.13.
  • As of June 30, 2026, 29 institutional investment managers tracked by SignalX reported holding Kimball Electronics, Inc. (KE) shares worth $269.4 million in 13F-HR filings.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2026
$1.4B
−3.7% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
29 funds
$269.4M · +1 vs prior quarter
Latest 8-K
Aug 12, 2026
Item 2.02

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Jun 30, 2026

Full analysis →

Management Discussion & Analysis

  • Revenue $1,431.4M, down 4% YoY from $1,486.7M; automotive sales fell 7% to $656.9M, medical grew to $412.8M (+4%), industrial down 5% to $361.7M
  • Operating margin 4.6% vs 3.1%; gross margin 8.2% vs 7.0%; S&A 4.3% vs 3.4%; net income $28M, EPS $1.13 vs $17M, $0.68, +64.6%
  • Medical segment best performer with 4% sales growth and margin contribution; automotive worst with 7% sales decline due to lost major program
  • Operating cash flow $72.3M vs $183.9M; capex $51.7M vs $33.7M (incl. Indianapolis medical facility); repurchased $11.9M stock, total buybacks $115.6M to date; debt reduced $30.9M
  • 2027 outlook includes Helvoet acquisition integration, new Indianapolis facility start-up costs, tariff uncertainties, ongoing automotive weakness offset by medical growth, and tax rate variability due to geographic earnings mix

Risk Factors

  • Regulatory/legal risk: Supreme Court vacated IEEPA tariffs imposed in Feb 2025; resulting tariff refunds began in Q4 FY2026 impacting customer cost recoveries
  • Geopolitical/macroeconomic threat: Ongoing Middle East conflict involving U.S., Israel, and Iran risks supply chain disruptions and freight/component cost increases
  • Operational/supply chain vulnerability: Closure of Tampa facility completed FY2025; production shifted mainly to Mexico and Jasper plants, with ongoing restructuring expected
  • Competitive/market disruption risk: Loss of major automotive program in FY2026 caused 7% sales decline; pressure from competitors in mid-sized EMS space noted
  • Financial/structural risk: Acquisition of Helvoet (approx. $103M paid Jul 2026) creating integration costs and synergies risk; liquidity strong with $403.8M cash + credit lines as of June 30, 2026

Business Overview

  • Contract manufacturer and CDMO serving global customers with integrated supply chain solutions, extensive international operations in China, Mexico, Europe, India, Thailand
  • Completed largest acquisition to date: Helvoet on July 1, 2026, expanding manufacturing footprint into India and the Netherlands and adding precision molded plastics and medical device capabilities
  • Increased focus on AI deployment across engineering, manufacturing, quality, and back-office functions; compliance with evolving AI-specific laws (EU AI Act, Colorado AI Act) emphasized
  • Inflation, tariffs, and supply chain disruptions increased costs; tariffs recovered mainly through contractual pass-through; currency fluctuations positively impacted net sales by 2%
  • Workforce and facility expansion complexity heightened, alongside intensified cybersecurity risks and regulatory compliance pressures, including global data privacy and sustainability requirements

AI summary of the KE 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Mar 31, 2026

Management Discussion & Analysis

  • Revenue $352.9M, down 6% YoY from $374.6M
  • Gross margin 7.9% vs 7.2%; operating margin 3.3% vs 3.1%
  • Best segment Medical revenue $106.1M, down 8%; worst Industrial revenue $86.3M, down 8%
  • Operating cash flow $29.8M through nine months vs $105.9M; capital investments $43.2M
  • Tariffs, geopolitical tensions, demand weakness, and component-cost pressures remain near-term headwinds

Risk Factors

  • No material risk-factor changes disclosed from the June 30, 2025 Form 10-K
  • Equity concentration risk: $4.0 million repurchased during the quarter
  • Capital allocation risk: $6.5 million remaining under the stock repurchase plan
  • Compliance risk: no officers or directors adopted or terminated Rule 10b5-1 trading plans during the quarter

AI summary of the KE 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Aug 12, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Fiscal fourth-quarter results ended June 30, 2026, released August 12, 2026
  • Earnings release attached as Exhibit 99.1, containing the substantive financial results

Item EX-99.1: Item EX-99.1

  • Q4 sales $371.6M, down 2% YoY, while adjusted operating margin declined to 4.9% from 5.2%
  • FY2026 sales $1,431.4M, down 4%; Medical grew 4% to $412.8M and reached 29% of sales
Filed Jul 1, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Forward-looking disclosure covering fiscal 2026 expectations and projections
  • Key risks: global conditions, geopolitical conflicts, health emergencies, tariffs, and trade barriers

Item 1.01: Entry into a Material Definitive Agreement

  • Kimball Electronics acquired Helvoet Polymer Technologies and Helvoet India from Hydratec Industries
  • Acquisition closed July 1, 2026, shortly after signing on June 26, 2026

Item EX-99.1: Item EX-99.1

  • Helvoet acquisition for €90 million, approximately $103 million, funded with cash and existing credit lines
  • European medical CDMO adds facilities in the Netherlands and India, expanding Kimball’s global manufacturing footprint
Filed May 5, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q3 fiscal 2026 earnings release covers the quarter ended March 31, 2026
  • Results, guidance, and management commentary available in Exhibit 99.1

Item EX-99.1: Item EX-99.1

  • Q3 revenue $352.9M, down 6% YoY but up 3.4% sequentially, signaling stabilization after weaker demand
  • Medical sales rose 10.2% sequentially; prior-year comparison pressured by a $24M non-recurring inventory sale

AI summaries of KE 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for KE

Don't miss the next KE filing

  • Alerts as it files. A push when KE files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut KE, by share count.
  • Ask anything. An AI agent that reads every KE filing and answers with sources.

KE alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Korn Steven TGSep 3, 2026-
Korn Steven TGSep 3, 2026-
Hass DouglasMAug 24, 2026-
Korn Steven TAAug 24, 2026-
Hass DouglasAAug 24, 2026-
Hass DouglasFAug 24, 2026$22.73
Korn Steven TAAug 24, 2026-
Korn Steven TMAug 24, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2024FY2025FY2026
Profitability
Revenue-$1.5B$1.4B
Gross Profit-$104.4M$117.5M
Operating Income-$45.5M$66.1M
Net Income-$17.0M$28.0M
Gross Margin-7.0%8.2%
Op. Margin-3.1%4.6%
Net Margin-1.1%2.0%
Balance Sheet
Total Assets$1.2B$1.1B$1.1B
Equity$540.5M$569.9M$585.1M
ROE-3.0%4.8%
Per Share
EPS-$0.68$1.13
Cash Flow
Operating CF-$183.9M$72.3M
CapEx-$33.3M$51.5M

Source: XBRL data in Kimball Electronics, Inc. (KE)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q2 2026

Aggregate KE share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
KE shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q2 202629$269.4M
Q1 202628$240.2M
Q4 202529$272.0M
Q3 202528$297.9M
Q2 202527$187.9M
Q1 202522$125.0M
Q4 202418$113.2M
Q3 202416$76.4M
Position changes: Q1 2026 → Q2 2026
Top Buyers
Top Sellers
New Positions
Closed Positions
None this quarter.

Source: 13F-HR filings on SEC EDGAR (aggregated from 197 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

KE filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Sep 4, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
10-KAug 19, 2026Analysis
SC 13GAug 14, 2026-
8-KAug 12, 2026Analysis-
8-KJul 1, 2026Analysis-
4Jun 3, 2026-
4Jun 3, 2026-
4May 28, 2026-
10-QMay 6, 2026Analysis
8-KMay 5, 2026Analysis-
SC 13GApr 30, 2026-
8-KMar 19, 2026Analysis-
10-QFeb 5, 2026Analysis
8-KFeb 4, 2026-
8-KJan 8, 2026-
4Jan 6, 2026-
10-QNov 6, 2025Analysis

Related Information Technology companies

All Information Technology →

KE SEC filings: frequently asked questions

Which institutions hold KE stock?

As of June 30, 2026, the largest Kimball Electronics, Inc. (KE) holders among the 13F filers tracked by SignalX were BlackRock ($62.5 million), Dimensional Fund Advisors ($42.4 million), Bank of America Corp ($30.5 million), Vanguard Capital Management LLC ($27.3 million), Vanguard Portfolio Management LLC ($20.8 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was KE's revenue in fiscal year 2026?

For the fiscal year ended June 30, 2026 (FY2026), Kimball Electronics, Inc. (KE) reported revenue of $1.4 billion (down 3.7% from FY2025) and net income of $28.0 million. Diluted EPS was $1.13. The figures come from the XBRL data in the 10-K.

What are the main risks in KE's latest 10-K?

In the 10-K filed August 19, 2026, Kimball Electronics, Inc. (KE) flagged: Regulatory/legal risk: Supreme Court vacated IEEPA tariffs imposed in Feb 2025; resulting tariff refunds began in Q4 FY2026 impacting customer cost recoveries. Geopolitical/macroeconomic threat: Ongoing Middle East conflict involving U.S., Israel, and Iran risks supply chain disruptions and freight/component cost increases. (AI summary of the Risk Factors section.)

What did KE report in its latest 8-K?

Kimball Electronics, Inc. (KE) filed an 8-K on August 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Fiscal fourth-quarter results ended June 30, 2026, released August 12, 2026.

What are the latest KE SEC filings?

Kimball Electronics, Inc. (KE) filed its latest 10-K annual report on August 19, 2026, a 10-Q quarterly report on May 6, 2026, an 8-K current report on August 12, 2026 and a Form 4 insider filing on September 4, 2026.

What is KE's SEC CIK number?

Kimball Electronics, Inc. (KE)'s SEC Central Index Key (CIK) is 1606757. EDGAR lists every KE filing under that number.

Ask anything about KE

The research agent reads KE's filings, financials, insider trades and 13F holders, then answers with sources.